133 related articles for article (PubMed ID: 31362839)
1. [Nodulocystic eruption induced by sorafenib].
Chambelland A; Koeppel MC; Desmedt E; Fongue J; Buono JP; Berbis P; Delaporte E
Ann Dermatol Venereol; 2019 Oct; 146(10):646-654. PubMed ID: 31362839
[TBL] [Abstract][Full Text] [Related]
2. Psoriasiform drug eruption secondary to sorafenib: case series and review of the literature.
Ensslin CJ; Kao PH; Wu MY; Chang YY; Kuo TT; Hsieh CH; Hsieh SY; Yang CH; Miller LS
Cutis; 2019 Sep; 104(3):E11-E15. PubMed ID: 31675404
[TBL] [Abstract][Full Text] [Related]
3. Sorafenib-associated facial acneiform eruption.
Cohen PR
Dermatol Ther (Heidelb); 2015 Mar; 5(1):77-86. PubMed ID: 25539704
[TBL] [Abstract][Full Text] [Related]
4. Image Gallery: Sorafenib-induced acne of the buttocks.
Kiritsi D; Arnold AW
Br J Dermatol; 2017 Dec; 177(6):e351. PubMed ID: 29313937
[No Abstract] [Full Text] [Related]
5. Facial nodulocystic eruption induced by sorafenib in a patient with hepatocellular carcinoma.
Duran-Vian C; Gómez-Fernández C; Navarro-Fernández I; Del Cura LR; Alonso-Buznego L; González-Vela MC; González-López MA
Indian J Dermatol Venereol Leprol; 2020; 86(4):409-411. PubMed ID: 32415051
[No Abstract] [Full Text] [Related]
6. Leukocytoclastic vasculitis associated with sorafenib treatment for hepatocellular carcinoma.
Prejac J; Kekez D; Belev B; Kocić L; Bulimbašić S; Pleština S
Anticancer Drugs; 2020 Jan; 31(1):76-79. PubMed ID: 31567309
[TBL] [Abstract][Full Text] [Related]
7. Nodular-cystic eruption in course of sorafenib administration for hepatocarcinoma: An unconventional skin reaction requiring unconventional treatment.
Borgia F; Saitta C; Vaccaro M; Franzè MS; Lentini M; Cannavò SP
Int J Immunopathol Pharmacol; 2017 Sep; 30(3):327-331. PubMed ID: 28825507
[TBL] [Abstract][Full Text] [Related]
8. Multikinase inhibitor sorafenib induces skin toxicities in tumor-bearing mice.
Tian A; Lu H; Zhang J; Fu S; Jiang Z; Lam W; Guan F; Chen L; Feng L; Cheng Y
Cancer Chemother Pharmacol; 2018 Jun; 81(6):1025-1033. PubMed ID: 29633006
[TBL] [Abstract][Full Text] [Related]
9. Sorafenib-induced psoriasiform eruption in a patient with metastatic thyroid carcinoma.
Diamantis ML; Chon SY
J Drugs Dermatol; 2010 Feb; 9(2):169-71. PubMed ID: 20214183
[TBL] [Abstract][Full Text] [Related]
10. Successful Treatment of Hepatocellular Carcinoma with Regorafenib after Sorafenib-induced Hypersensitivity.
Yoshioka N; Kuzuya T; Ito T; Ishizu Y; Honda T; Ishikawa T; Ishigami M; Fujishiro M
Intern Med; 2019 Oct; 58(19):2803-2808. PubMed ID: 31243207
[TBL] [Abstract][Full Text] [Related]
11. Sorafenib-induced Facial Acneiform Eruption.
Mijares MC; Aldahan AS; Gonzalez HH; Jaimes JP
Cureus; 2019 Apr; 11(4):e4545. PubMed ID: 31275769
[TBL] [Abstract][Full Text] [Related]
12. Cutaneous drug eruptions induced by sorafenib: a case series.
Maddox JS; Kung EF; Petronic-Rosic V; Sethi A
J Drugs Dermatol; 2008 Sep; 7(9):891-3. PubMed ID: 19112807
[TBL] [Abstract][Full Text] [Related]
13. A prospective clinical trial on sorafenib treatment of hepatocellular carcinoma before liver transplantation.
Eilard MS; Andersson M; Naredi P; Geronymakis C; Lindnér P; Cahlin C; Bennet W; Rizell M
BMC Cancer; 2019 Jun; 19(1):568. PubMed ID: 31185950
[TBL] [Abstract][Full Text] [Related]
14. Effect of everolimus on survival in advanced hepatocellular carcinoma after failure of sorafenib: the EVOLVE-1 randomized clinical trial.
Zhu AX; Kudo M; Assenat E; Cattan S; Kang YK; Lim HY; Poon RT; Blanc JF; Vogel A; Chen CL; Dorval E; Peck-Radosavljevic M; Santoro A; Daniele B; Furuse J; Jappe A; Perraud K; Anak O; Sellami DB; Chen LT
JAMA; 2014 Jul; 312(1):57-67. PubMed ID: 25058218
[TBL] [Abstract][Full Text] [Related]
15. Sorafenib-associated psoriasiform eruption in a patient with hepatocellular carcinoma.
İlknur T; Akarsu S; Çarsanbali S; Lebe B; Fetil E
J Drugs Dermatol; 2014 Aug; 13(8):899-900. PubMed ID: 25116964
[No Abstract] [Full Text] [Related]
16. Safety and efficacy of cytotoxic chemotherapy in hepatocellular carcinoma after first-line treatment with sorafenib.
da Fonseca LG; Marta GN; Braghiroli MIFM; Chagas AL; Carrilho FJ; Hoff PM; Sabbaga J
BMC Cancer; 2018 Dec; 18(1):1250. PubMed ID: 30545331
[TBL] [Abstract][Full Text] [Related]
17. Multikinase inhibitor-associated hand-foot skin reaction as a predictor of outcomes in patients with hepatocellular carcinoma treated with sorafenib.
Ochi M; Kamoshida T; Ohkawara A; Ohkawara H; Kakinoki N; Hirai S; Yanaka A
World J Gastroenterol; 2018 Jul; 24(28):3155-3162. PubMed ID: 30065561
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial.
Vilgrain V; Pereira H; Assenat E; Guiu B; Ilonca AD; Pageaux GP; Sibert A; Bouattour M; Lebtahi R; Allaham W; Barraud H; Laurent V; Mathias E; Bronowicki JP; Tasu JP; Perdrisot R; Silvain C; Gerolami R; Mundler O; Seitz JF; Vidal V; Aubé C; Oberti F; Couturier O; Brenot-Rossi I; Raoul JL; Sarran A; Costentin C; Itti E; Luciani A; Adam R; Lewin M; Samuel D; Ronot M; Dinut A; Castera L; Chatellier G;
Lancet Oncol; 2017 Dec; 18(12):1624-1636. PubMed ID: 29107679
[TBL] [Abstract][Full Text] [Related]
19. Strategies for assessing and managing the adverse events of sorafenib and other targeted therapies in the treatment of renal cell and hepatocellular carcinoma: recommendations from a European nursing task group.
Edmonds K; Hull D; Spencer-Shaw A; Koldenhof J; Chrysou M; Boers-Doets C; Molassiotis A
Eur J Oncol Nurs; 2012 Apr; 16(2):172-84. PubMed ID: 21641280
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial.
Cheng AL; Kang YK; Chen Z; Tsao CJ; Qin S; Kim JS; Luo R; Feng J; Ye S; Yang TS; Xu J; Sun Y; Liang H; Liu J; Wang J; Tak WY; Pan H; Burock K; Zou J; Voliotis D; Guan Z
Lancet Oncol; 2009 Jan; 10(1):25-34. PubMed ID: 19095497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
